Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Shareholder Satisfaction Survey on RTA Services'.

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.3%1-day move

₹1776.00

prior close

₹1787.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.1+0.5+0.3+0.3-1.5-0.3-1.6-1.3+1.0-6.8-5.7+7.2+2.5

Up moveDown movePending

AI summary

Sun Pharmaceutical Industries has launched a Shareholder Satisfaction Survey to gather feedback on the services provided by its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited (formerly Link Intime India Private Limited). The survey is open from 17 March 2026 to 31 March 2026. Only shareholders who used RTA services between 1 April 2025 and 31 December 2025 are eligible to participate, and they will receive email invitations. The aim is to improve service quality, efficiency, and responsiveness to shareholder needs.

Likely market impact

This is a routine corporate governance and shareholder engagement initiative with no material impact on the company's financials or stock price. It reflects the company's effort to improve shareholder services.